en · de · es · fr · pt
cardarine-notes.peptides3081.com › Guide › Preclinical Findings And Safety Signals — Hands-On Walkthrough

Preclinical Findings And Safety Signals — Hands-On Walkthrough

By Editorial Desk · published 2026-05-15 · last reviewed 2026-07-03 · Guide

If you have been reading about nuclear receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2026-07-03. Where a claim depends on a specific study, the study is described rather than over-claimed.

Preclinical Findings and Safety Signals

Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.

Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.

Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.

Background and Regulatory History

Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.

GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.

Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.

Cardarine at a glance

PropertyValueNotes
Primary targetPPARδ (NR1C2)Nuclear receptor involved in lipid metabolism
Preclinical effectIncreased fatty acid oxidationObserved in rodent studies
Key safety signalTumors in rodents after long-term exposureContributed to halted clinical development
Human trial statusNo approved product; development stoppedLimited short-term metabolic data
Sport regulatory statusProhibited at all timesWADA hormone and metabolic modulators class

Mechanism and Research Context

Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.

In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.

Related pages on this site

Background and Research Context

Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.

PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.

In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.

Background from the literature

The Meeting of Teano between Garibaldi and King Victor Emmanuel II of Savoy took place on 26 October 1860, where he annexed Mezzogiorno. On 19 August 1860, Calabria was invaded from Sicily by Giuseppe Garibaldi and his Redshirts as part of the Expedition of the Thousand. Through King Francesco II of Naples had dispatched 16,000 soldiers to stop the Redshirts, who numbered about 3,500, after a token battle at Reggio Calabria won by the Redshirts, all resistance ceased and Garibaldi was welcomed as a liberator from the oppressive rule of the Bourbons wherever he went in Calabria. Calabria together with the rest of the Kingdom of Naples was incorporated in 1861 into the Kingdom of Italy. Garibaldi planned to complete the Risorgimento by invading Rome, still ruled by the pope protected by a French garrison, and began with semi-official encouragement to raise an army. Subsequently, King Victor Emmanuel II decided the possibility of war with France was too dangerous, and on 29 August 1862 Garibaldi's base in the Calabrian town of Aspromonte was attacked by the Regio Esercito. The Battle of Aspromonte ended with the Redshirts defeated with several being executed after surrendering while Garibaldi was badly wounded. With the plebiscite of 21 October 1860, Calabria and the other southern provinces became part of the Kingdom of Sardinia: consequently, elections were called to allow the newly annexed territories to select representation in Parliament. The election was held on 27 January 1861, and the new Parliament was inaugurated in Turin on February 18.

In response to US threats, Greenland's prime minister Jens-Frederik Nielsen said Trump would not "get" Greenland and that it is not for sale. The US threats have caused a pause in independence discussions, which Nielsen promoted during the previous elections. The PM stated that, "when faced with the choice between US and Denmark, Greenland chooses Denmark". A joint statement published by all parties in the Parliament of Greenland demanded that the US show respect and that they do not want to become part of the US, that they "do not want to be Americans." Greenland has moved to ban foreign political funding in response to US interference. 2025 and 2026 saw large demonstrations against the US in Greenland, with Greenlanders emphasising that "we are not for sale". Demonstrators carried placards bearing the slogans "no means no", "stop threatening us", and "Yankee go home!" On 12 January 2026, the government of Greenland issued a statement that they can "not under any circumstances" accept US demands for Greenland to become part of the US and that "Greenland is part of the Kingdom of Denmark", underlining the role of NATO in its defence. The government welcomed the initiative by six NATO members (reported to be the UK, Germany, France, Italy, Poland, and Spain) to increase NATO activity in Greenland.

== History == Many theories of the origin of the Weimaraner have been advanced, but there are few documented historical facts; silver-grey dogs are shown in paintings by Antoon van Dyck in the seventeenth century and by Jean-Baptiste Oudry in the eighteenth. The breed is believed to have originated in the area of the city of Weimar (then in Saxe-Weimar-Eisenach, now in the state of Thuringia) – the city from which its name derives. It is sometimes claimed that the dogs were kept at the court of Karl August, Grand Duke of Saxe-Weimar-Eisenach, in the early nineteenth century. From 1879 the dogs were considered to be a blue variant of the German Short-haired Pointer, and were eligible for registration in the stud-book of the Kurzhaar Klub. They first appeared at a dog show in 1880, when fourteen examples were presented in Berlin. These were of three differing types, from three different kennels: the traditional Thüringer Hund; the Weißenfelser Hund, which was rather more elegant; and the Sanderslebener, which was intermediate between the two. The Weimaraner was recognised as a distinct breed in 1891. A breed standard was drawn up in 1896, and in 1897 a breed association was established in Erfurt with the name Verein zur Reinzucht des silbergrauen Weimaraner-Vorstehhund; this was soon changed to Verein zur Züchtung des Weimaraner Vorstehhundes. In the early years of the twentieth century – the time of the Great War – the Weimaraner came close to extinction; it was reconstituted from the few surviving examples of the breed.

Sources: en.wikipedia.org

Further detail

in the PAMn matrix which results in the best score is most likely to correspond to the mutations per amino acid separating the two proteins. Halving this value and dividing by the rate at which accepted mutations accumulate in the protein family provides an estimate of the time of divergence of these two proteins from their common ancestor. That is, the time of divergence in myr is

== Applications == If an oscillating U-tube is filled with water and pistons are placed at each end, pressure exerted by the left piston will be transmitted throughout the liquid and against the bottom of the right piston. (The pistons are simply "plugs" that can slide freely but snugly inside the tube.) The pressure that the left piston exerts against the water will be exactly equal to the pressure the water exerts against the right piston

A field ration is a type of prepackaged military ration designed to be easily and quickly prepared and consumed in the field, in combat, at the front line, or where eating facilities are otherwise unavailable. Field rations are primarily used by military forces, though they are also sometimes distributed to civilians as part of humanitarian aid and emergency management. Field rations differ from garrison rations and field kitchen provisions, which are intended for where proper meals can be supplied and prepared with relative ease and safety, such as in the rear where logistics are steady and fresh food can be supplied. They are similar to, but distinct from, other purpose-designed long-lasting types of food or rations such as emergency rations, humanitarian daily rations, and camping food. Names used for field rations vary by military and type, and include combat ration, ration pack, battle ration, iron ration, food packet, operational ration pack, or meal ready-to-eat (MRE); the latter is widely used but informal, and more accurately describes a specific U.S. field ration, the design and configuration of which has been used worldwide since its introduction in the late 20th century. Field rations may be divided into two types: individual rations, which are intended to sustain a single soldier; and group rations, which are intended to sustain multiple soldiers in numbers ranging from a fireteam to a platoon. Furthermore, field rations may come individually packaged per meal, or contain items intended to be consumed in multiple meals throughout the day.

A written description of a trial/study of any therapeutic, prophylactic, or diagnostic agent conducted in human subjects, in which the clinical and statistical description, presentations, and analyses are fully integrated into a single report. (ICH E6) Clinician

Sources: en.wikipedia.org

Supporting material

Insects as food or edible insects are insect species used for human consumption. Over 2 billion people are estimated to eat insects on a daily basis. Globally, more than 2,000 insect species are considered edible, though far fewer are discussed for industrialized mass production and regionally authorized for use in food. Many insects are highly nutritious, though nutritional content depends on species and other factors such as diet and age. Insects offer a wide variety of flavors and are commonly consumed whole or pulverized for use in dishes and processed food products such as burger patties, pasta, or snacks. Like other foods, there can be risks associated with consuming insects, such as allergic reactions. As commercial interest in insects as food grows, countries are introducing new regulatory frameworks to oversee their production, processing, marketing, and consumption.

bioenergetics The branch of biochemistry and cell biology that studies the flow of energy through living systems, in particular how organisms acquire, produce, transform, and utilize energy in order to perform biochemical work such as metabolic reactions.

The group takes its name from Mighei (Ukraine), but the most famous member is the extensively studied Murchison meteorite. Many falls of this type have been observed and CM chondrites are known to contain a rich mix of complex organic compounds such as amino-acids and purine/pyrimidine nucleobases. CM chondrite famous falls:

Sources: en.wikipedia.org

Frequently asked questions

What did animal studies show?

Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.

Has cardarine been tested in humans?

Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.

Does cardarine improve athletic performance in people?

Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.

Is cardarine a selective androgen receptor modulator?

No. Cardarine is a PPARδ agonist, while selective androgen receptor modulators act on androgen receptors. The two classes differ in receptor target and downstream effects.

Network